scout
News|Videos|May 30, 2024

BTK Inhibitors in CLL: Second Generation Drugs and Beyond

Dr. Constantine Tam provides an overview of the current and emerging treatment landscape for chronic lymphocytic leukemia (CLL), with a focus on Bruton's tyrosine kinase (BTK) inhibitors like ibrutinib and the next generation of BTK inhibitors under development.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME